Main > ENDOCRINOLOGY > Diabetes. Treatment > Meglitinide Class Drugs > NateGlinide. > NonGeneric Nateglinide

---

NonGeneric Nateglinide's subsections
Action: Enhances Insulin Secretion
Adm. Route: Oral; 60 & 120 mg Doses
Licensee
Licensor
Marketing
Patent.
Production By:
Status.
TradeMark
Web-Site

NonGeneric Nateglinide's products
This section has no products